Premium
Long‐term survival after central nervous system relapse in a patient with osteosarcoma
Author(s) -
Wexler Leonard H.,
Delaney Thomas F.,
Saris Stephen,
Horowitz Marc E.
Publication year - 1993
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19930815)72:4<1203::aid-cncr2820720412>3.0.co;2-p
Subject(s) - medicine , osteosarcoma , adjuvant , chemotherapy , central nervous system , radiation therapy , metastasis , adjuvant chemotherapy , disease , surgery , adjuvant therapy , oncology , cancer , pathology , breast cancer
Background . Since the advent of multiagent adjuvant chemotherapy, survival among patients with localized osteosarcoma has improved to 60% or more. Pulmonary relapse, the most common cause of treatment failure, is associated with less than 25% long‐term survival; central nervous system (CNS) metastasis, when it occurs, often presents as a catastrophic clinical event in preterminal patients. Methods . The authors report a patient with osteosarcoma who had an isolated pulmonary relapse and a subsequent isolated CNS relapse. Complete surgical resection was accomplished on both occasions and followed in the initial instance by adjuvant chemotherapy and in the latter instance by adjuvant whole‐brain irradiation. Results . An isolated CNS metastasis was resected and adjuvant whole brain irradiation was administered; the patient is alive and relapse free more than 5 years later. Conclusions . Patients with osteosarcoma in whom isolated, resectable metastases develop can derive benefit from gross total resection followed by adjuvant chemotherapy or radiation therapy for microscopic residual disease.